Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
This is our current range 120p +\- 5p. Until we get news from our board or Sierra get 737 moving. I do still feel that PH have driven the price down and expect when they get advanced news of results that they will announce a II and will buy in at this lower rate, potentially 30 million shares, so roughly 100 million shares in circulation. Just my view.
I have voted through HL, you have to instruct them, either by secure email when you log in or you can call them snd instruct. You need to do this at least 5 days prior to the AGM. You should have had an email from them. I would get your vote in ASAP.
I cast my vote “for” earlier in the week, having been here for 10+ years and kept patient, we are about to head into a higher devision assuming the proposals go through. SAR will have positioned the company to push ahead and avoid the need for low ball offers. In short they have more choice in how to maximise value and progress development.
SAR as a business will need to create the ability to raise significant funds to progress there / our 1801 ++. So this is what it looks like to me. Consolidate 50/1 equates to around 69 / 70 million shares, then a II could take a 30 million option giving a round 100 million shares. The value post consolidation with news …. Let’s say £2.5 / £5.0. This would provide a platform to progress to stage 2 ++. Now big Pharm have either to make a move very soon or post stage 2 when less risk. Either way we need a position that demonstrates we are not open to low ball offers. Hhhmm
Having held for a very long time, it is disappointing that we are not informed of the strategy to move the business forward, we need clarity so we can make an informed decision and vote accordingly. Having looked at the voting time table EGM 28th, votes by the 26th and HL my broker wants 5 clear days prior to register my votes then I need more from our board beforehand. I am currently undecided which way to vote.
Just watched the Edison interview with Tim, my view is that he was suite excited in places. It was good to see the Sar position summarised although he was talking / reading fast. We just need to sit on our hands until we have firm results.
The trouble is that our board are very poor at communicating, there is little evidence of commercial matters and managing the share price. Tim and co are clever people in there field but the forward facing PR is none existent. We have an experienced Chairman who should be guiding the business. It is hard not to be negative with our guys. Let’s hope that the rabbit comes out the hat very soon.
Azzz I understand and get your thinking, my point is around the poor coms, there is a distinct lack of thought in how things are worded which can and does have an impact on the share price. Yes we can trade our positions or invest, I am in the invest camp and I expect that the board act with commercial awareness, unfortunately this is lacking, so why not have a more commercial leader to exploit the share value. Unless there is any pressure brought to the board then it’s “ more of the same”’
After a very disappointing week, let’s see what follows over the next week. I do feel that the board must up there game and protect the share holders that have provided them with the cash to advance the various products. I want to see them deliver on at least one front with concrete results. My personal view is we should push for a EGM in Q1 if we don’t have a any substantial results. Our guys are great scientists but we need a commercial leader now. I also think that our chairman should be driving this as it’s his corporate guidance that should be leading this, otherwise he should step down or be voted out. I do believe in the science but my faith in the board is waining.
It’s a painful few days as our board under perform, they seem to on a different planet at times. They seem either oblivious to share holder sentiment or they just don’t care. There have now been a few signs to me that they don’t really care. Time for a shake up and a need for a more professional board, the science is great but as to generating value then not at the party. Surely they can manage the news / information much better, I do feel we should hold there feet to the fire at the AGM
There some brilliant people on this board and have been here a long time, the research has advised us of the potential of our various molecules and the company has protected the future value with patents so all good so far. In regards to value, we have massive potential but the medical and science world work on facts, so it’s all potential until we get through the trials and can validate with data. We do have the annoying delays and the 737 that could be our first success, this would fuel our other molecules and value. It is a waiting game, we must just sit it out for now.
Look, our Directors wanted some cash so they liquidated a few shares, what’s wrong in that ….nothing when you are sat on millions of shares. I sold some a few weeks ago as need some cash, I have millions left so when our boat comes in then I will be loaded, so as I say why not sell a few if it suits.
It has been some time now since we had a investor session. It could be they have nothing to say or more likely they don’t / can’t face questions that may compromise any deals that are being discussed. I have little understanding of the science but have board room experience of large buy in / outs, so it looks to me as though we are deep in discussions with potential suitors. The due diligence takes ages and it is also likely tied into the patents and data timelines. Given we have a patent due shortly, I am assuming this will be the catalyst for a company update.